Lead: Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023
Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023 Drug and Alcohol Dependence Gabapentin prescriptions ha...
18 Helmi 8min
Lead: Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer This study analyzed data...
10 Helmi 7min
Lead: Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities
Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities JAMA Network Open This study examined the availability of medications for alcohol use disorder (MAUD) in...
3 Helmi 6min
Lead: Public Views About Opioid Overdose and People With Opioid Use Disorder
Public Views About Opioid Overdose and People With Opioid Use Disorder JAMA Network Open This study completed a national web-based survey of 1552 adults in the United States in April 2025 to assess pe...
27 Tammi 6min
Lead: Did the illicit fentanyl trade experience a supply shock?
Did the illicit fentanyl trade experience a supply shock? Science In the United States overdose deaths (ODDs) from synthetic opioids peaked in mid-2023 and then began a sharp decline decreasing by ove...
21 Tammi 6min
Lead: Barriers to Buprenorphine Initiation in Patients Using Fentanyl
Barriers to Buprenorphine Initiation in Patients Using Fentanyl JAMA Network Open This is a survey study of 396 buprenorphine-prescribing clinicians in the US to determine if they faced problems initi...
13 Tammi 6min
Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023
Productivity Losses From Substance Use Disorder in the U.S. in 2023 American Journal of Preventive Medicine Information on morbidity-related productivity losses attributable to substance use disorder ...
16 Joulu 20257min
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations Substance Use and Addiction Journal This is a narrative review of methadone and buprenorphine regulation...
9 Joulu 20255min
